HIA
Harbor Investment Advisory’s Edwards Lifesciences EW Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.75M | Sell |
22,340
-167
| -0.7% | -$13.1K | 0.16% | 111 |
|
2025
Q1 | $1.63M | Buy |
22,507
+4,682
| +26% | +$339K | 0.16% | 108 |
|
2024
Q4 | $1.32M | Buy |
17,825
+1,442
| +9% | +$107K | 0.12% | 126 |
|
2024
Q3 | $1.08M | Buy |
16,383
+2,339
| +17% | +$154K | 0.11% | 148 |
|
2024
Q2 | $1.3M | Buy |
14,044
+19
| +0.1% | +$1.76K | 0.14% | 118 |
|
2024
Q1 | $1.34M | Buy |
14,025
+396
| +3% | +$37.8K | 0.14% | 116 |
|
2023
Q4 | $1.04M | Buy |
13,629
+3,080
| +29% | +$235K | 0.12% | 135 |
|
2023
Q3 | $731K | Buy |
10,549
+1,518
| +17% | +$105K | 0.1% | 161 |
|
2023
Q2 | $852K | Buy |
9,031
+1,531
| +20% | +$144K | 0.12% | 156 |
|
2023
Q1 | $620K | Buy |
7,500
+597
| +9% | +$49.4K | 0.09% | 175 |
|
2022
Q4 | $515K | Buy |
6,903
+125
| +2% | +$9.33K | 0.08% | 200 |
|
2022
Q3 | $560K | Buy |
6,778
+232
| +4% | +$19.2K | 0.09% | 182 |
|
2022
Q2 | $622K | Buy |
6,546
+72
| +1% | +$6.84K | 0.1% | 173 |
|
2022
Q1 | $762K | Buy |
6,474
+8
| +0.1% | +$942 | 0.1% | 167 |
|
2021
Q4 | $838K | Sell |
6,466
-2,358
| -27% | -$306K | 0.11% | 159 |
|
2021
Q3 | $999K | Buy |
8,824
+67
| +0.8% | +$7.59K | 0.14% | 129 |
|
2021
Q2 | $907K | Buy |
8,757
+20
| +0.2% | +$2.07K | 0.12% | 143 |
|
2021
Q1 | $731K | Buy |
8,737
+15
| +0.2% | +$1.26K | 0.11% | 156 |
|
2020
Q4 | $796K | Buy |
8,722
+114
| +1% | +$10.4K | 0.13% | 137 |
|
2020
Q3 | $687K | Sell |
8,608
-1,829
| -18% | -$146K | 0.13% | 132 |
|
2020
Q2 | $721K | Buy |
10,437
+5,320
| +104% | +$368K | 0.15% | 116 |
|
2020
Q1 | $965K | Buy |
5,117
+689
| +16% | +$130K | 0.26% | 87 |
|
2019
Q4 | $1.03M | Buy |
+4,428
| New | +$1.03M | 0.24% | 95 |
|